Objective-Smooth muscle cells (SMCs) are the most abundant cells in human atherosclerotic lesions and are suggested to contribute at least 50% of atheroma foam cells. In mice, SMCs contribute fewer total lesional cells. The purpose of this study was to determine the contribution of SMCs to total foam cells in apolipoprotein E-deficient (ApoE −/− ) mice, and the utility of these mice to model human SMC foam cell biology and interventions. Approach and Results-Using flow cytometry, foam cells in the aortic arch of ApoE −/− mice were characterized based on the expression of leukocyte-specific markers. Nonleukocyte foam cells increased from 37% of total foam cells in 27-weekold to 75% in 57-week-old male ApoE −/− mice fed a chow diet and were ≈70% in male and female ApoE −/− mice following 6 weeks of Western diet feeding. A similar contribution to total foam cells by SMCs was found using SMC-lineage tracing ApoE −/− mice fed the Western diet for 6 or 12 weeks. Nonleukocyte foam cells contributed a similar percentage of total atheroma cholesterol and exhibited lower expression of the cholesterol exporter ABCA1 (ATP-binding cassette transporter A1) when compared with leukocyte-derived foam cells. Conclusions-Consistent with previous studies of human atheromas, we present evidence that SMCs contribute the majority of atheroma foam cells in ApoE −/− mice fed a Western diet and a chow diet for longer periods. Reduced expression of ABCA1, also seen in human intimal SMCs, suggests a common mechanism for formation of SMC foam cells across species, and represents a novel target to enhance atherosclerosis regression. Visual Overview-An online visual overview is available for this article. 
R etention of lipoprotein cholesterol in artery walls is considered the key driver of atherosclerotic plaque formation, 1 and removal of this cholesterol is a requirement for plaque regression. 2 In the past 25 years studies of arterial cholesterol metabolism have focused primarily on mouse models, and on the role of monocytederived macrophages in taking up excess cholesterol and driving plaque formation, inflammation, and progression. 3 Macrophages have been called the most abundant cell type in mouse atherosclerotic plaque, 4 and inhibition of initial monocyte recruitment into the mouse artery wall can nearly abolish plaque development. 5, 6 See accompanying editorial on page 836
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In contrast to mice and most animal models of atherosclerosis, 7 humans develop a thick layer of smooth muscle cells (SMCs) in the intima known as diffuse intimal thickening (DIT) beginning in utero in atherosclerosis-prone arteries. 8 Proteoglycans secreted by DIT SMCs promote the initial retention of apoB (apolipoprotein B)-containing lipoproteins predominantly in the deep intima, away from macrophages that accumulate initially in the immediate subendothelial space. 9 Autopsy studies of young adults in the 1980s suggested SMCs are a major contributor to cholesterol-overloaded foam cells in early stages of atherosclerosis. 10 We previously presented evidence suggesting at least 50% of foam cells in human coronary artery atheromas are SMC derived. 11 We also found that SMCs in human coronary intima have reduced expression of the rate-limiting promoter of cholesterol efflux, ABCA1 (ATPbinding cassette transporter A1), when compared with intimal leukocytes. 11 Lower ABCA1 expression suggests a potential reason for SMCs to become foam cells, and that SMC foam cells in plaque may be resistant to cholesterol efflux-dependent regression when compared with macrophage foam cells. 12 The relative contribution of SMCs to total foam cells in mouse atherosclerosis has not previously been determined. Such analysis has been difficult because of the fact that arterial intimal SMCs frequently express macrophage markers. On cholesterol loading cultured mouse arterial SMCs show decreased expression of classic SMC markers such as SMA (SMC α-actin) and myosin heavy chain and increased expression of macrophage markers, including CD68 and Mac-2. 13 Feil et al 14 reported expression of macrophage markers by intimal SMCs in mice, and that a high number of intimal SMCs take up oxidized LDL (low-density lipoprotein), but did not quantitate the relative contribution of SMCs and macrophages to the total foam cell population. Further studies from the Owens group, using ApoE-deficient mice expressing an SMC-lineage tracing marker, estimated that >80% of intimal SMCs lack classic SMC markers. 15 Unlike human arterial intima where up to 90% of cells may be SMCs, 16 these studies estimated SMCs constitute ≈36% of total cells in advanced mouse plaque, but also did not quantitate the contribution of SMCs to foam cells.
The much lower contribution of SMCs to total intimal cells in mice compared with humans, absence of DIT in mice, and the previously documented numeric and functional importance of macrophages in mouse atherosclerosis led us to hypothesize that macrophages would comprise the majority of foam cells in ApoE-deficient mice. This could potentially represent a fundamental limitation in the use of mice to understand human SMC foam cell biology. In the current studies, we used a flow cytometry method to investigate the contribution of SMC foam cells to the total foam cell population in ApoE-deficient mice fed a chow diet for 27 and 57 weeks or a Western diet (WD) for 6 or 12 weeks, and the relative expression of ABCA1 by leukocyte-and nonleukocyte-derived foam cells. Contrary to our expectation, our data using both SMC nonlineage-tracing and lineage-tracing mice suggest SMCs contribute the majority of total foam cells in both WD-and older chow-fed ApoEdeficient mice. Similar to human intimal SMCs, we also found reduced expression of ABCA1 in SMC-derived compared with macrophage-derived foam cells in these mice.
Materials and Methods
The data that support the findings of this study are available from the corresponding author upon reasonable request.
The authors declare that all supporting data are available within the article and its in the online-only Data Supplement or from the corresponding author on request. Additional Methods are available in the online-only Data Supplement.
Animal Procedures
Eight-week-old male and female ApoE −/− mice on a C57BL/6 background (Jackson Laboratory) were fed a WD (21% fat, 0.2% cholesterol, Harland Teklad) for 6 weeks to generate early to intermediate lesions without foam cell apoptosis or necrosis. To study spontaneous atherosclerosis, male ApoE −/− mice were fed a chow diet until sacrifice at 27, 36, and 57 weeks. Aortas were collected from the base of the aorta at the aortic valve up to the diaphragm, and adventitia and surrounding adipose tissue were removed. For immunostaining experiments aortic roots were cut from the atria to the apex of the heart and frozen in optimal cutting temperature compound, except for those from 36-week-old chow-fed mice which were fixed in 10% neutral buffered formalin for later lipid fixation studies. The remaining aortas were cut into 2 sections, one containing the ascending aorta and aortic arch (lesion-prone) and the other the descending aorta (lesion-resistant) for flow cytometry. Small sections of both aortic segments were collected for histology studies. All procedures were performed in accordance with guidelines of the Canadian Council on Animal Care and were approved by the University of British Columbia Animal Care Committee. Male Myh11-Cre SMC lineage-tracing mice (Tomato mice) were generated at Stanford University as described in Methods in the online-only Data Supplement, using a rainbow reporter as described previously 17 or a Tomato reporter(Jackson Laboratory, B6.Cg-Gt(ROSA)26Sor tm14(CAG-tdTomato)Hze / J). For all studies using SMC-lineage tracing mice, only male animals were available because the Cre allele was initially inserted into the Y chromosome (Jackson Laboratory, B6.FVB-Tg(Myh11-cre/ ERT2)1Soff/J).
Immunofluorescence and Confocal Microscopy
Serial sections (5 μm) of aortic root beyond the end of the aortic sinus were selected for staining. 18 Sections were blocked with 5% goat serum before incubating with rabbit anti-SMA(Abcam, 0.5 µg/mL) or rat anti-CD45 (BD Pharmingen, 5 µg/mL) primary antibodies. Goat anti-rabbit Alexa fluor595 or goat anti-rabbit Alexa fluor532 was used as secondary antibodies for probing SMA, and goat anti-rat Alexa fluor633 secondary antibody for CD45. Foam cells were stained with 10 μg/mL BODIPY 493/503 (Invitrogen) at the same time as secondary antibodies. Z-stacked images using 8 planes of the same region were captured using a Leica scanning confocal microscope and analyzed by Volocity (PerkinElmer). Formalin-fixed aortic roots were treated using a lipid fixation protocol before being embedded in paraffin.
19

Flow Cytometry Method Validation
A collagen gel system 20 was created to evaluate the effect of the tissue digestion and flow cytometry procedure on foam cell quantitation. To attempt this comparison in tissue, individual lesions were isolated from Tomato SMC lineage-tracing mice, dissected vertically into 2 parts of similar sizes, and foam cell composition analyzed by flow cytometry and confocal cell counting separately.
Flow Cytometry Quantification of Foam Cell Composition and ABCA1 Expression
Aortic segments were first fixed in 1% formaldehyde in PBS for 10 minutes. Fixation was stopped with 125 mmol/L glycine to avoid over cross-linking and allow later chromatin immunoprecipitation (ChIP) analysis. Tissues were then washed in PBS, cut into 3 mm pieces, and digested with 4 U/mL Liberase TM (Roche), 60 U/mL hyaluronidase type 1-s, and 60 U/mL DNase I in PBS at 37°C for 1 hour with gentle shaking. After digestion, the cell suspension was passed through a 70 μm cell strainer and spun down at 600 g for 5 minutes to collect the cell pellet for fluorescence-activated cell sorting (FACS). Cell pellets were resuspended in PBS containing 1% BSA and 0.1% NaN 3 and incubated with mouse Fc block (BD Pharmingen) for 10 minutes at 4°C, and then with 10 μg/mL BODIPY 493/503 and fluorescenceconjugated antibodies for 30 minutes at room temperature. After washing, cells were resuspended in 20 μg/mL propidium iodide in PBS and sorted within 1 hour using a MoFlo Astrios EQ cell sorter (Beckman). BV421 rat anti-mouse CD45, V500 rat anti-mouse I-A/I-E (BD Pharmingen), and Alexa Fluor647 rat anti-mouse ABCA1 (AbD Serotec) antibodies were used according to manufacturer's instructions. Fluorescence minus one controls were applied to facilitate gating of CD45 and I-A/I-E and to make compensations when necessary. BODIPY 493/503 fluorescence intensity of lesion-free descending 
Preparation of LDL
LDL was isolated from the serum of healthy donors by sequential ultracentrifugation 21 and was dialyzed at 4°C against PBS pH 7.5. Aggregated LDL was made by vortexing for 1 minute.
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Cholesterol Mass and Efflux Assays
Cholesterol mass in isolated foam cells as determined by mass spectrometry and cholesterol efflux from cultured mouse macrophages, and SMCs were determined using established methods as described in the online-only Data Supplement.
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ChIP Assay
For WD-fed ApoE −/− mice, foam cells negative for both CD45 and I-A/I-E, or positive for either leukocyte marker were sorted separately into ChIP lysis buffer. Sorted foam cells from 3 animals of the same sex were pooled together for microChIP assay, and enrichment level of dimethylation in lysine 4 of histone H3 at the MYH11 locus was determined to indicate cells of SMC lineage as described previously 27 using a low cell number ChIP kit (Diagenode). The enrichment levels of this epigenetic mark were also determined in cultured mouse aortic SMCs (MASMCs) and RAW 264.7 macrophages.
Statistics
Results were analyzed by SPSS and GraphPad Prism for statistical significance between treatment groups. Normality of data was determined using a D'Agostino and Pearson omnibus normality test (α=0.05) and by visual inspection of normality using Q-Q plots. Homogeneity of variance was determined by performing either an F-test or a Levene test. Suitable parametric or nonparametric tests were used as indicated in the figure legends. Data are presented as mean±SEM. P values <0.05 were considered significant.
Results
Absence of DIT and Limitations of Histological Lineage-Tracing of Foam Cells in Atherosclerotic Lesions of ApoE -/-Mice
In human atherosclerosis-prone arteries, including coronaries and aorta, DIT composed of SMCs and their secreted proteoglycans forms an intima beginning in utero, 8 which frequently exceeds the thickness of the medial SMC layer in adulthood, regardless of the presence of overt atheroma ( Figure 1A , upper). In ApoE −/− mice there is no DIT layer; 6 weeks of WD feeding produces foam cell-rich intimal lesions in the aortic roots ( Figure 1A , lower). Movat's Pentachrome stains SMCs deep red; the vacuolization in medial layer SMCs may be a response to the metabolic stress of the hyperlipidemia 28 but is not because of lipid deposition ( Figure 2A ). To determine the feasibility of quantitating and lineage-tracing foam cells in mouse lesions histologically, we used a lipid preservation technique 19 that previously allowed us to quantitate individual foam cells in human coronary atheromas. 11 Aortas from 36-week-old ApoE −/− mice fed a chow diet were treated to fix lipids and then incubated with Oil Red O and antibody against SMA. Figure 1B 
Validation of Flow Cytometry-Based Isolation and Quantification of Foam Cells
Based on these difficulties using traditional histological and confocal microscopy methods, we used and tested the validity of tissue digestion and flow cytometry to isolate and characterize the origin of foam cells from mouse atheromas. As traditional macrophage markers such as CD68 are also expressed in intimal SMCs, 14 we first identified foam cells based on their lipid levels using BODIPY 493/503. By microscopy, the descending aorta and medial layer of aortic arch showed abundant SMA expression and weak or no BODIPY staining ( Figure 2A , left and right), while the intima of aortic arches of ApoE −/− mice fed a WD for 6 weeks contained foam cellrich lesions that stained strongly for BODIPY and weakly for SMA (Figure 2A, right) . The lower lipid level of cells isolated from lesion-free descending aortas was, therefore, used to set low and high thresholds of lipid content to identify foam cells (Figure 2Ba A potential concern of this method is that foam cells of either SMC or leukocyte lineage might be more sensitive than the other to the digestion condition and lost during the isolation process. To test the validity of the tissue digestion method, the fidelity of foam cell quantitation following tissue digestion and FACS was tested in a collagen gel model with MASMCs and RAW 264.7 mouse macrophages cocultured in a collagen sandwich structure. 20 We found that foam cell composition determined by FACS following digestion of the collagen gel did not differ from results obtained by counting cells in undigested collagen gel sections by microscopy ( Figure I in the online-only Data Supplement).
We also validated the use of CD45 as a marker to separate leukocyte-derived from nonleukocyte-derived foam cells. We found no expression of CD45 in cultured MASMCs ( Figure  IIA and IIB in the online-only Data Supplement) on lipid loading. However, a reduction of CD45 fluorescence intensity was seen in RAW 264.7 macrophages treated with aggregated LDL ( Figure IIA in the online-only Data Supplement), suggesting that macrophages may exhibit reduced CD45 expression on lipid loading.
Seventy Percent of Foam Cells in Early-Stage Atherosclerotic Lesions Are Nonleukocyte-Derived
Based on the known loss of SMC-specific markers by the majority of mouse intimal SMCs, 15 foam cells in lesion-bearing aortas from WD fed mice (Figure 2Ca ; Lipid high ) were analyzed for expression of leukocyte-specific markers. Given the potential downregulation of surface CD45 in macrophagederived foam cells, foam cells were also separated based on expression of I-A/I-E, antigen-presenting cell markers that are expressed at a high level in activated leukocytes in atheromas. 29 Gates Q3 and Q4 and gates Q1 and Q4 were selected to indicate CD45 or I-A/I-E positivity, respectively (Figure 2Cd and 2Ce), using fluorescence minus one controls (Figure 2Ca and 2Cb). Expression of I-A/I-E by arterial SMCs has not been reported, and we found few CD45 − foam cells exhibiting expression of I-A/A-E (Figure 2Ce; Q1) . We, therefore, used the absence of CD45 and I-A/I-E to quantitate nonleukocytes in the foam cell populations ( Figure 2C , gate Q2). Gates Q3 and Q4 of Figure 2C method, we determined that in ApoE −/− mice fed a WD for 6 weeks, 69.47±3.20% (male) and 73.3±2.35% (female; n=9 mice of each sex) of the foam cell populations were nonleukocytes, significantly higher than leukocyte-derived foam cells (29.59±2.94% in male and 27.71±3.54% in female mice; P<0.01; Figure 2E ).
Nonleukocyte Foam Cells in Lesions of ApoE -/-
Mice Are Primarily of SMC Origin
To determine the contribution of SMCs to the nonleukocyte foam cell population, CD45 − (gate Q2) and CD45 + (gate Q3+Q4) foam cells were sorted to determine the enrichment level of dimethylation in lysine 4 of histone H3 at the MYH11 locus, a lineage-specific epigenetic marker of SMCs that persists despite their phenotypic changes during atherogenesis. 27 The SMC-specific marker was highly enriched in CD45 To confirm these data using an alternate approach, we determined the contribution to total atheroma foam cells and expression of CD45 by SMCs using SMC-lineage tracing ApoE −/− mice.
One recent publication reported that 2.6% of SMCs express CD45 in an SMC-lineage tracing wild-type mouse model. 30 We determined CD45 expression by arterial SMCs in SMC-lineage tracing ApoE −/− mice fed a WD for 6 weeks. In these mice with arterial SMCs labeled with intrinsic fluorescent proteins, <1% of SMCs were positive for CD45 ( Figure IIIB in the online-only Data Supplement, Q4 gates). Therefore, under the conditions of these experiments, CD45 can be assumed to be a leukocyte-specific marker. In these lineage tracing mice, where non-SMCs all express GFP (green fluorescent protein), 63.36±3. 
Nonleukocyte Contribution to Total Foam Cells and Cholesterol Accumulation in Spontaneous Atherosclerosis
Nonleukocyte contribution to total foam cells was also determined in male nonlineage-tracing ApoE −/− mice fed a chow diet to assess early (27 weeks) and late-stage (57 weeks) spontaneous atherosclerosis, using the same methods as in WD-fed animals. At age 27 foam cells among the total foam cell pool ( Figure 4B ). These data suggest that as lesions progress in the chow-fed mice, CD45 − foam cells become the predominant foam cell type and contribute an equivalent or higher amount of total foam cell cholesterol burden than CD45 + foam cells.
Nonleukocyte Foam Cells in ApoE -/-Mice Exhibit Reduced ABCA1 Expression
Based on our prior observation that intimal SMCs in human coronary atheromas exhibit reduced ABCA1 expression compared with either medial arterial SMCs 31 or intimal leukocytes, 11 we also determined ABCA1 expression in CD45 − and CD45 + foam cells from ApoE −/− mice. Compared with CD45 + leukocyte-derived foam cells, ABCA1 expression was lower in CD45 − foam cells from both female and male ApoE −/− mice fed a WD for 6 weeks, and male ApoE −/− mice fed a chow diet for 27 weeks ( Figure 5A ). Fold change of ABCA1 mRNA was also higher in cultured RAW 264.7 macrophages (4.39±0.14) compared with MASMCs (2.7±0.13) exposed to aggregated LDL ( Figure 5B), which was consistent with reduced ABCA1 protein level and reduced cholesterol efflux to apoA-I from MASMCs compared with RAW 264.7 macrophages ( Figure 5C ). These results are consistent with lower ABCA1 expression in CD45 − foam cells in vivo and suggest that there is impaired upregulation of ABCA1 expression and, therefore, cholesterol efflux in response to cholesterol loading in SMC relative to leukocyte foam cells.
Discussion
Current thinking about the main cell type of interest and primary site of cholesterol deposition in atherosclerotic plaque, based primarily on studies in mice, has ascribed these roles to macrophages. While we assumed macrophages would contribute the quantitative majority of foam cells in mouse atherosclerosis, in the current studies we provide evidence using both nonlineage-and SMC lineage-tracing models that SMCs contribute the majority of foam cells in apoE −/− mice fed a WD for 6 or 12 weeks or a chow diet for longer periods. While contrary to our initial hypothesis, these results are similar to our prior results in human coronary atheromas where we estimated that SMCs contribute, conservatively, at least 50% of total intimal foam cells. 11 Also consistent with human lesions, 11 we find that expression of the rate-limiting exporter of excess cell cholesterol, ABCA1, is reduced in CD45 − (primarily 
SMC-derived) compared with CD45
+ (leukocyte-derived) foam cells. Reduced ABCA1 expression provides a potential reason for the accumulation of SMC-relative to macrophagederived foam cells, and also suggests SMC foam cells may be more resistant to regression than macrophage foam cells in atherosclerotic lesions.
We initially attempted to quantitate foam cells using a similar histological approach used in human lesions. Application of this method to mice is limited by a much greater loss of SMC-specific cell markers including ACTA2/SMA in mouse 15 compared with human intimal SMCs. 11 Utility of the leukocyte-specific marker CD45, as validated in the current studies (Figures II through IV in the online-only Data Supplement), was restricted because of loss of cell CD45 immunoreactivity following the lipid fixation technique we previously adapted to distinguish intracellular from extracellular lipid in human lesions. 19 Without lipid fixation, however, intracellular and extracellular lipid deposits cannot be distinguished from one another, making it impossible to accurately count individual foam cells in histological sections ( Figure 1C ; Figure V in the online-only Data Supplement). We, therefore, developed a tissue digestion and flow cytometry protocol to isolate and lineage-trace foam cells from mouse atheromas. Although flow cytometry is an established method to analyze cell populations from digested arteries, 15 ,32 the methods used might preferentially isolate one lineage of foam cells over another. While the limitations of tissue histological foam cell quantitation preclude direct comparison with FACS analysis, we performed this comparison using a 3-dimensional collagen macrophage and SMC coculture model. We obtained similar quantitation of SMC-and macrophage-foam cells by both methods ( Figure I in the online-only Data Supplement). While the collagen gel system does not mimic directly arterial tissue structure, these results suggest that the tissue digestion and FACS-based approach does not preferentially isolate one lineage of foam cell over the other.
In vivo, cholesterol content in the mixed multilineage cell populations from digested vessels is heterogeneous and presented as a continuous spectrum between nonfoam cells and foam cells (Figure 2B and 2C) . To isolate foam cells in arterial lesions for lineage analysis, we characterized the lipid content of cells isolated from lesion-bearing aortic arch with + and CD45 − foam cells from ApoE −/− mice fed a Western diet (WD) for 6 wk (left) or 27-week-old male ApoE −/− mice fed a chow diet (right) determined as the median fluorescence of ABCA1 intensity by flow cytometry. For WD-fed mice, **P<0.01 using 2-way ANOVA, n=9 mice/group; there was no statistical difference between the 2 sexes. For chow-fed mice, **P<0.01 using Mann-Whitney U test, n=5 mice/group. B, Fold change of ABCA1 mRNA level in RAW 264.7 macrophages and MASMCs treated with 100 g/mL aggregated LDL (agLDL) as compared to fatty acid-free albumin alone for 24 h. *P<0.05, using Welch t test. C, ABCA1 protein levels and cholesterol efflux from RAW 264.7 macrophages and MASMCs treated with 100 µg/mL agLDL for 48 h followed by incubation with 0.3 mmol/L 8Br-cAMP±10 µg/mL (for efflux) for 24 h. Cholesterol efflux was determined by liquid chromatography-mass spectrometry and normalized by total cell protein levels*P<0.05 and **P<0.01 using 2-tailed Mann-Whitney U test, N=5.
lesion-resistant descending aorta. By this technique, we were able to set a consistent threshold of lipid content to isolate cholesterol-enriched foam cells based on the level of BODIPY staining, previously used to identify neutral lipid droplets in flow cytometry 33, 34 ( Figure 2B ). We found a 7-to 10-fold increase in cholesterol content in cells above (Lipid 36 Stellate pericyte-like cells have also been reported to accumulate lipids in human atherosclerotic lesions. 37 Overall, our data from SMC lineage-tracing and nonlineage-tracing ApoE −/− mice suggest that following 6 or 12 weeks of WD feedings, or from older apoE −/− mice fed a chow diet, 63% to 70% of foam cells are SMC-derived, with the majority of our data indicating this percentage is ≈70%. The similar results using nonlineage-and lineage-tracing mice indicates non-SMC-lineage tracing will remain useful for future studies of SMC foam cell biology, depending on the question being asked.
Our data suggesting the majority of foam cells are SMCderived was unexpected. First, mice lack the DIT layer of SMCs present from birth in atherosclerosis-prone arteries in humans. 7 Medial to intimal migration of SMCs is dependent on secretion of cytokines released by endothelial cells following injury induced by the hyperlipidemia and by monocytes/ macrophages that migrate into the intima in the earliest stages of atherogenesis. [38] [39] [40] Second, SMCs are estimated to comprise only ≈36% of total intimal cells in advanced ApoE −/− mouse lesions. 15 Our estimate that ≈70% of foam cells in these mice are SMC-derived, therefore, suggests SMCs are either more predisposed to accumulate cholesterol than macrophages, or less likely to release excess cholesterol once it is deposited in the cells. SMCs express a variety of scavenger receptors including LRP1 (low-density lipoprotein-related protein 1) capable of taking up modified lipoproteins. 12 In addition to the known capacity of SMCs to take up modified forms of LDL, we demonstrate for the first time that mouse nonleukocyte foam cells, similar to human intimal SMCs 11 have reduced expression of ABCA1, the rate-limiting promoter of cholesterol efflux from foam cells, 41 when compared with leukocyte-derived foam cells in both WD and chow-fed ApoE −/− mice ( Figure 5 ). Failure to release excess cholesterol via ABCA1 once it is deposited may, therefore, be the primary reason SMCs become the main lineage of foam cell. In support of this, even at 27 weeks of chow feeding, where CD45 − cells make up only 37% of foam cells, they contain almost 50% of the cholesterol in the total foam cell population ( Figure 4B ), and fail to upregulate ABCA1 as readily as CD45 + foam cells ( Figure 5A , right). This suggests SMCs have a defect in the pathway upregulating ABCA1 expression, resulting in them shifting to become the majority of foam cells after 57 weeks of chow diet ( Figure 4A, right) . Upregulation of ABCA1 expression is dependent on upstream processing of lipoproteins and generation of oxysterols from lysosomally derived cholesterol to activate ABCA1 transcription. 42 While KLF4 has been described as a master regulator of the switch of intimal SMCs from an SMC towards a macrophage-like phenotype in lesions, ABCA1 expression was not found to be a target of KLF4. 15 This implies that a defect intrinsic to arterial SMCs, irrespective of their phenotype, may be responsible for their reduced upregulation of ABCA1 in response to lipid loading when compared with leukocytes. This possibility and the relative ability of macrophage and SMC foam cells to release excess cholesterol during regression of atherosclerosis require further investigation.
The results presented here seem counter to previous studies showing that bone marrow-derived leukocytes are the key factor determining the size and cellular content of mouse lesions. In particular, combined inhibition of multiple chemokine pathways in monocytosis reduced lesion size by 90% in ApoE −/− mice. 6 The interfering strategies used in these and many other studies aimed at reducing monocyte infiltration into the plaque, however, may hinder any downstream effects of monocyte recruitment including stimulation of SMC migration from the media into the intima. We observed that the formation of MASMC foam cells in the presence of aggregated LDL was enhanced by coculturing with RAW 264.7 macrophages ( Figure VII in the online-only Data Supplement). While the mechanism of this remains to be determined, this indicates an additional mechanism, at least in mice, promoting SMC foam cell formation.
Considering the relationship of our findings to previous work allows us to compare and contrast human and mouse atherogenesis. As indicated in the model shown in Figure 6 , a key difference is the lack of the SMC DIT layer in mice. In humans, initial lipid deposition occurs around these SMCs deep in the intima and away from macrophages. In mice, initial foam cell formation is primarily from macrophages, with SMCs moving into the plaque later under the influence of endothelial cell and leukocyte-secreted cytokines. While some in vitro studies indicate SMC migration from the media may occur parallel to lipid loading in mouse lesions, 43 and medial layer SMC foam cells have been reported in a canine model, 44 we did not find evidence of lipid accumulation in medial SMCs in aortic arches with early-stage lesions in our mice (Figure 2A ). Whether the formation of SMC foam cells in the medial layer with subsequent migration to the intima can occur requires further investigation. Our model suggests that, following these different initial events in the 2 species, SMCs are (human) or become (mouse) the predominant cell lineage contributing to total foam cells, because of lack of ABCA1-dependent cholesterol efflux from SMCs in both species.
Not addressed in this study is the relationship of SMC foam cell formation to expansion of specific clones of SMCs in the intima, and whether SMCs continue to proliferate after becoming foam cells. These studies as well as the transferability of the results to other animal models of atherosclerosis require further investigation.
In conclusion, our current and previous results suggest SMCs are the source of the majority of foam cells in both human 11 and established mouse atherosclerosis, and that ABCA1 expression is low in intimal SMCs in both species. These findings have major implications for our understanding of atherosclerosis pathogenesis and suggest SMC foam cells may be resistant to regression. Determining the mechanism of impaired ABCA1 regulation in arterial intimal SMCs will be critical to designing novel treatments to remove the large fraction of excess artery wall cholesterol held in SMC-derived foam cells. Such therapies may be necessary to reduce myocardial infarctions and stroke beyond what current LDL-lowering therapies can achieve. 8 At the onset of atherosclerosis lipoproteins that diffuse into the artery wall are trapped through a charge-charge interaction with SMC-secreted proteoglycans, primarily in the deep intima. 7 These trapped lipoproteins are modified and aggregated, becoming a substrate for uptake by the surrounding SMCs. At this stage, monocyte/macrophages are located primarily in the subendothelial region away from the deposited lipids. 9 Over time both SMCs and macrophages take up modified lipoproteins to become foam cells independently and interactively. ABCA1 (ATP-binding cassette transporter A1; red dots), the rate-limiting cholesterol efflux promoter, is robustly upregulated in macrophage foam cells, but less so in SMC foam cells. Increased ABCA1 expression facilitates cholesterol removal out of macrophage-derived foam cells, while impaired ABCA1 expression reduces cholesterol efflux from SMC foam cells, resulting in SMCs being the predominant lineage among total foam cells. In ApoE −/− mice, no DIT SMC layer is present. Atherogenic lipoproteins induce endothelial injury and monocyte binding and infiltration into the intima, where they mature into macrophages that take up the modified intimal lipids. Cytokines released by injured endothelial cells and monocytes/macrophages, including PDGF (platelet-derived growth factor), TNF-α (tumor necrosis factor-alpha), and IL-1β (interleukin-1beta) induce SMC migration from the media into the intima. SMCs proliferate in the intima and take up modified lipoproteins to become foam cells. Similar to human lesions, the SMC foam cells exhibit reduced ABCA1 expression compared with macrophages. Over time the total contribution to foam cells shifts from macrophages to SMCs, due at least in part to impaired ABCA1 expression by the SMC foam cells.
